BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  AIT Bioscience Welcomes New Chief Scientific Officer

  Anderson replaces Ronald E. Shoup, Ph.D. in this role.

  December 21, 2017

   · 

  2 min read
• BioMidwest

  AIT Bioscience Among Inc.'s 5000 Fastest Growing Private Companies

  The list represents a unique look at the most successful companies within the American economy’s most dynamic segment.

  December 21, 2017

   · 

  3 min read
• Business

  Open Accelerator Announces Winning Life Science Start-Ups

  Zcube today announces the winners of the second edition of its Open Accelerator programme aimed at Life Science start-ups and entirely supported by the Italian company: Zambon.

  December 21, 2017

   · 

  3 min read
• Drug Development

  Sanifit Announces Last Patient Last Visit completed in Clinical Trial of SNF472 in Patients with Calciphylaxis

  Laboratoris Sanifit S.L. announced today that the Last Patient’s Last Visit occurred in the Phase II study of SNF472.

  December 21, 2017

   · 

  3 min read
• Immunovia Release: Sahlgrenska University Hospital First Swedish Site in the Largest Ever Prospective Clinical Study for Early Detection of Pancreatic Cancer

  Immunovia today announced that Sahlgrenska University Hospital is the first Swedish site to be part of PanFAM-1, a multicenter prospective validation study for the early diagnosis in familiar pancreatic cancer high risk individuals.

  December 21, 2017

   · 

  3 min read
• Policy

  rfxcel Approved as a Technically Certified Connection Provider for EMVO

  rfXcel has been confirmed as a Technically Certified Connection Provider by the EMVO.

  December 21, 2017

   · 

  1 min read
• Pharm Country

  Windtree Therapeutics Announces Reverse Stock Split

  Windtree Therapeutics today announced a 1-for-20 reverse stock split of its issued and outstanding common stock.

  December 21, 2017

   · 

  3 min read
• BioMidwest

  First-in-Human Trial of New Immunotherapy Approach Shows Efficacy in Antibiotic Resistance

  SAb Biotherapeutics announced today its first-in-human trial of new immunotherapy approach has shown efficacy in antibiotic-resistant bacteria based on a recent paper published online in Clinical Infectious Diseases.

  December 21, 2017

   · 

  3 min read
• Policy

  Emmaus Life Sciences Sickle Cell Treatment Receives Positive Opinion on Pediatric Investigation Plan from European Medicines Agency

  Emmaus Life Sciences announced today that the Paediatric Committee (PDCO) of the European Medicines Agency (EMA) has accepted the company’s pediatric investigation plan (PIP) for its treatment of sickle cell disease.

  December 21, 2017

   · 

  3 min read
• 

  Business

  Histogenics, MEDINET Ink Pact for Development and Commercialization of NeoCart for the Japanese Market

  Transaction Terms Include a $10M Up-front Payment with a Potential of $87m in Total Milestones, and Tiered Royalties on Sales

  December 21, 2017

   · 

  9 min read